ISSN 1301 - 0883 / E-ISSN 1339 - 3886
 
 







 
 
Search





Hyaluran is a biomarker in patients without sepsis-related liver injury or not? [Eastern J Med]
Eastern J Med. 2019; 24(3): 283-288 | DOI: 10.5505/ejm.2019.94899  

Hyaluran is a biomarker in patients without sepsis-related liver injury or not?

İlhan Bahar1, Gülseren Elay2, Adnan Bayram3
1İlhan BAHAR Katip Çelebi University, Atatürk Education and Research Hospital Internal Intensive Care, Izmir, Turkey,
2Gülseren ELAY Ersin Aslan Training and Research Hospital Intensive Care Anesthesiology, Gaziantep, Turkey
3Adnan BAYRAM Erciyes University Medical Faculty of Anesthesiology and Reanimation, Kayseri, Turkey

INTRODUCTION: The aim of the present study is to evaluate the value of hyaluran (HA) as a biomarker of sepsis in patients not showing sepsis-associated liver dysfunction and to investigate the relationship between HA level and disease severity
METHODS: Sepsis patients that had been followed-up between 2015 and 2016 in intensive care unit of Erciyes University Hospital were included in this prospective study. Sepsis was defined according to the 2013 Sepsis Survival Campaign Guidelines. The patients were classified as sepsis, severe sepsis, and septic shock. Blood samples were collected from the patients on the first and the third days to measure the HA level. A single blood sample was collected from each subject in the control group. The demographic characteristics, the duration of intensive care unit stay, and mortality data of the patient and the control groups were analyzed.
RESULTS: A total of 46 patients and 30 control subjects were evaluated. HA levels were found to be higher in the sepsis group than the others. HA was neither a predictor of the disease mortality, nor was it correlated with the inflammatory markers, C-reactive protein (CRP), and procalcitonin (PCT).

DISCUSSION AND CONCLUSION: HA is not a sepsis biomarker in the patients with sepsis who do not show sepsis-associated liver dysfunction.

Keywords: Hyaluronan, Sepsis, Mortality


İlhan Bahar, Gülseren Elay, Adnan Bayram. Hyaluran is a biomarker in patients without sepsis-related liver injury or not?. Eastern J Med. 2019; 24(3): 283-288

Corresponding Author: Adnan Bayram, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
Copyright © 2019 Eastern Journal of Medicine. All Rights Reserved.
Home        |        Contact
LookUs & OnlineMakale